Cargando…
A novel GPI-anchored dominant-negative TGF-β receptor II renders T cells unresponsive to TGF-β signaling
Transforming growth factor β (TGF-β) is a pleiotropic cytokine expressed by a wide range of cell types and is known for hampering the effectiveness of cancer immune cell therapeutic approaches. We have designed a novel construct containing the extracellular domain of the TGF-β receptor II linked to...
Autores principales: | Petersen, Sven H., Al Badawy, Kays, Hopkins, Richard, Vu, Dang L., Rahmani, Mehran, Maia, Sonia M.P., Connolly, John E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565558/ https://www.ncbi.nlm.nih.gov/pubmed/37829123 http://dx.doi.org/10.1016/j.omto.2023.100730 |
Ejemplares similares
-
Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralization
por: Powell, Allison B., et al.
Publicado: (2019) -
PredGPI: a GPI-anchor predictor
por: Pierleoni, Andrea, et al.
Publicado: (2008) -
GPI-anchor and GPI-anchored protein expression in PMM2-CDG patients
por: de la Morena-Barrio, Maria E, et al.
Publicado: (2013) -
Complexities of TGF-β Targeted Cancer Therapy
por: Connolly, Erin C., et al.
Publicado: (2012) -
TGFβ-mediated expression of TGFβ-activating integrins in SSc monocytes: disturbed activation of latent TGFβ?
por: van Caam, A., et al.
Publicado: (2020)